Who are Apollo Therapeutics's investors?

Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, AlbionVC, UCL Technology Fund, IP Group.

How much funding has Apollo Therapeutics raised?

Apollo Therapeutics has disclosed $226.5M raised across 1 round.

Where is Apollo Therapeutics headquartered?

Apollo Therapeutics is headquartered in Cambridge, GB.

Apollo Therapeutics

Cambridge, GB · 6 known investors

Find your way into Apollo Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Apollo Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines. The company develops a diversified pipeline of drug candidates through partnerships with top research institutions and selective in-licensing of clinical-stage programs.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Richard Butt Chief Scientific OfficerRichard Butt is Chief Scientific Officer of Apollo Therapeutics, a biopharmaceutical company developing drug candidates through partnerships with leading academic research institutions.

Sanjay Aggarwal Chief Medical OfficerSanjay Aggarwal is a pharmaceutical physician with international clinical development experience across oncology, hematology, respiratory, metabolic, and infectious diseases, holding qualifications in internal medicine (MRCP UK) and an MBA.

Investors · 6

Patient Square Capital✓ confirmed by Apollo TherapeuticsMenlo Park

How we know: Patient Square Capital's portfolio page · the company's own site · funding news · apollotx.com · Not right? Tell us

Rock Springs Capital✓ confirmed by Apollo TherapeuticsBaltimore

How we know: the company's own site · imperial.ac.uk · Not right? Tell us

AlbionVClisted by AlbionVCLondon

How we know: AlbionVC's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

UCL Technology Fundlisted by UCL Technology FundLondon · $320K – $9M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

IP GroupreportedLondon

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 1

M&G plc

Funding

SEC filings, press & company announcements

$226.5M disclosed across 1 round · 2023

$226.5MSeries CSep 2023 · 3 sources
Patient Square Capital (lead), M&G plc, Rock Springs Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital | Apollo Therapeuticsapollotx.com · Sep 2023

Team | Apollo Therapeuticsapollotx.com · Jul 2023

About Us | Apollo Therapeuticsapollotx.com · Jul 2023

Frequently asked questions

What does Apollo Therapeutics do?: A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines. The company develops a diversified pipeline of drug candidates through partnerships with top research institutions and selective in-licensing of clinical-stage programs.
Who are Apollo Therapeutics's investors?: Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, AlbionVC, UCL Technology Fund, IP Group.
How much funding has Apollo Therapeutics raised?: Apollo Therapeutics has disclosed $226.5M raised across 1 round.
Where is Apollo Therapeutics headquartered?: Apollo Therapeutics is headquartered in Cambridge, GB.